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Abstract
Purpose: Heavy metals, such as lead can cause optic neuropathy. Optic disc neuropathy due to lead
intoxication has previously been reported. We report a rare case of lead toxicity-induced optic neuropathy
presenting with bilateral hemorrhagic optic disc swelling.
Case Report: The patient was a 42-year-old man with a history of chronic oral opium use, who had a
gradually progressing blurred vision in both eyes over 40 days, with ataxia, paresthesia, and a toxic level
of serum lead. He had been treated with lead chelators for lead poisoning. His color vision was impaired in
both eyes. Humphrey’s visual field test revealed double arcuate scotomawith enlargement of the blind spot.
Funduscopy revealed bilateral optic disc swelling, which was confirmed on optical coherence tomography
and fluorescein angiography.
Conclusion: In cases of optic disc edema, a comprehensive history should be taken to detect the cause.
Further, in cases of chronic oral opium use, lead toxicity should be considered.
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Optic disc swelling or edema can be unilateral or
bilateral. Bilateral disc edema can occur due to
increased intracranial pressure (ICP), inflammatory
processes, toxic agents, nutritional deficit or hyper-
tensive emergencies.[1]
Toxic optic neuropathies are a group of dis-
orders defined as visual impairment caused by
damage to the optic nerve by a toxin. This condition
often presents as a progressive, painless bilateral
vision decline with central or cecocentral scotoma
and reduced color vision.[2]
Heavymetals are a group of toxic agents that can
cause toxic optic neuropathy. Lead poisoning is a
common cause of metal toxicity. There are several
sources of lead exposure, such as paint, gasoline,
cosmetic products, and batteries. Absorption of
lead occurs via the respiratory and gastrointestinal
tracts.[3] The most common symptom in lead toxic-
ity is systemic hypertension. The neurotoxic effects
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of lead on the human body are clinically well-
known, including optic neuropathy.[4] The retina, as
a part of the central nervous system, is sensitive
to lead toxicity.[5] Lead accumulation in the retinal
pigment epithelium (RPE) can cause apoptosis of
the photoreceptors, especially rods, which can be
detected as decreased sensitivity and amplitudes
of dark-adapted electroretinogram (ERG) waves.
This condition may present with peripheral retinal
pigmentary changes.[5–7] The aim of this report
was to describe bilateral optic neuropathy, a rare
ocular manifestation of lead toxicity, in a patient
with opium addiction, which was evaluated using
clinical examinations, laboratory tests, and multi-
modal imaging.
CASE REPORT
A 42-year-old male shopkeeper was referred to
the Neuro-ophthalmology Clinic at the Rassoul
Akram Hospital, Tehran, Iran with blurred vision
in both eyes. The patient complained of gradual
progression of bilateral vision decline, ataxia, and
paresthesia of the lower extremities over the past
40 days. Results of brainmagnetic resonance imag-
ing (MRI) with and without contrast were normal,
and the ICP was within normal limits. The patient’s
medical records indicated that the serum lead level
was 164 µg/dL (normal upper limit: 20 µg/dL). One
month before the referral, he had been treated with
intravenous sodium calcium edetate (disodium cal-
cium ethylenediaminetetraacetic acid [EDTA]) for
five days by a neurologist. Subsequently, succimer
(2,3-dimercaptosuccinic acid) was orally adminis-
tered for two weeks. A week later, his neurological
symptoms improved, and the lead level in his serum
dropped to 36 µg/dL. Before treatment, the patient
had not undergone eye evaluation. Shortly after the
completion of chelation therapy, he came to our
neuro-ophthalmology clinic for the evaluation of
persistent blurred vision in both eyes, although he
reported subjective improvement in visual acuity
after chelation therapy. His medical and family
histories were unremarkable. His blood pressure
was 115/80 mm Hg. He had used oral opium for
over 10 years but did not drink alcohol. With the
Snellen chart, his best-corrected visual acuity was
5/10 at a distance of 6 m in the right eye and “count
fingers” at a distance of 3 m in the left eye. There
was no vision improvement in the pinhole test in
either eye. His pupillary reactions were normal in
both eyes, with a relative afferent defect in the left
eye. Extraocular motility was intact in both eyes.
The intraocular pressure was 14 mm Hg in both
eyes on Goldmann applanation tonometry. The
Ishihara test scores were 9/14 and 1/14 for the right
and left eyes, respectively. Slit-lamp examination
was unremarkable. His dilated fundus exam was
significant for hyperemia, hemorrhage, and edema
of the retinal nerve fiber layer surrounding both
optic discs [Figure 1]. Optic nerve pallor was not
present. The macula, peripheral vascular struc-
tures, and retinal periphery were unremarkable in
both eyes. The Humphrey visual field test showed
double arcuate scotoma with enlargement of the
blind spot and severe generalized depression of
the right eye [Figure 2]. The visual field of the left
eye was severely depressed, and the patient could
not undergo perimetry. Peripapillary optical coher-
ence tomography (OCT) demonstrated increased
thickness of the retinal nerve fiber layer (RNFL) in all
four quadrants of both eyes [Figure 3]. Fluorescein
angiography detected disc leakage in both eyes
[Figure 4].
The patient underwent lead toxicity treatment
with chelating agents (EDTA and succimer) and
showed a good response with a decreased serum
lead level. He was advised to attend follow-up visits
to monitor the resolution of optic neuropathy with
clinical and paraclinical tests. However, the patient
did not return for follow-up visits to detect clinical
and/or paraclinical progression or regression of the
disease.
DISCUSSION
Sources of lead include old paint, old plumbing,
glass-making, dust exposure, battery burning, and
soldering.[5] However, our patient was not exposed
to any of these sources or risks. He was a chronic
oral opium user, and recently, the opium used by
him contained lead as a chemical impurity. Lead is
occasionally added to opium products to increase
its weight for higher profits.[8]
Lead poisoning can cause systemic hyper-
tension, which can cause hypertensive optic
neuropathy.[5] However, the patient had no his-
tory of systemic hypertension. According to the
patient’s medical records at the time of presenta-
tion, his blood pressure was 115/80 mm Hg with
no evidence of accelerated or malignant hyperten-
sion. Moreover, cotton-wool spots, hard exudates,
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Figure 1. Fundus photographs show significant hyperemia and edema of both optic discs.
Figure 2. Humphrey’s visual field test of the right eye (SITA standard 24-2) shows double arcuate scotoma with enlargement of
the blind spot and severe generalized depression.
Elschnig spots, and Siegrist streaks, which are
indicative of hypertensive chorioretinopathy were
absent [Figures 1 and 4].
Toxic optic neuropathies typically present with a
gradually progressive, bilaterally symmetric, pain-
less vision loss affecting the central vision. Poison-
ing with heavy metals, such as lead, can cause
toxic optic neuropathy.[9, 10] Lead exposure has a
toxic effect on the macular, choroidal, and RNFLs,
which causes visual deficits.[11] Our patient had a
progressive, painless bilateral visual acuity decre-
ment, color vision impairment, and visual field
defects.
Bilateral optic disc neuropathywith lead intoxica-
tion has previously been reported. Baghdassarian
reported a 49-year-old male paint-shop worker
who had bilateral optic neuropathy and showed
laboratory evidence of lead poisoning.[4] Therefore,
our patient with bilateral hemorrhagic optic disc
edema, as indicated on funduscopy and imaging,
is a rare case.
Heavy metals, including lead, can accumulate
in human pigmented ocular tissues, particularly
in RPE and the choroid, resulting in decreased
sensitivity and amplitude of the a- and b-waves
of the dark-adapted ERG.[5] Lead exposure causes
retinal degeneration with selective loss of rods and
bipolar cells.[12] This is due to apoptosis of the pho-
toreceptor cells.[7] Lead can also cause disorders in
calcium metabolism of the photoreceptors.[7] Rod
degeneration in patients with lead retinal toxicity
can present with peripheral retinal pigmentary
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Figure 3. Spectral-domain optical coherence tomography shows increased reticular nerve fiber layer thickness in all four
quadrants in both eyes, suggestive of disc edema.
Figure 4. Fluorescein angiography shows disc leakage in both eyes, suggestive of disc edema.
alterations.[6] Our patient refused to undergo ERG
for further investigations. However, funduscopy
did not reveal any retinal peripheral abnormali-
ties.
Although neuroimaging shows normal results in
toxic optic neuropathy, it is almost always indicated
to rule out space-occupying lesions. The most
appropriate imaging modality is MRI of the optic
nerves and chiasm with and without gadolinium
enhancement.[2] Brain MRI of this patient was
unremarkable, with no enhancement of the optic
nerves, which did not favor the diagnosis of optic
neuritis.
The treatment of optic neuropathy due to
lead poisoning includes removing the sources
of lead exposure and chelation with EDTA and
succimer. Chelating agents for lead poisoning
can reduce the serum lead level and improve
the clinical and paraclinical features of toxic optic
neuropathy due to systemic lead poisoning.[5] For
example, Baghdassarian reported a patient
with bilateral optic neuropathy because of
systemic lead poisoning in whom the visual
acuity significantly improved and visual field
scotoma decreased after treatment with the
lead-chelator D-penicillamine and subsequent
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serum lead level reduction.[4] Our patient had
been treated with EDTA, and subsequently with
succimer. After the treatment, the serum lead level
decreased from 164 to 36 µg/dL. The neurological
symptoms disappeared, and visual acuity in both
eyes improved subjectively.
A limitation of this study is that we did not
measure the macular ganglion cell layer thickness
with OCT; it could help with the evaluation of cell
loss in cases of optic disc edema. Papilledema
is defined as optic disc edema due to increased
ICP and should be differentiated from papillitis.
The lumbar puncture in this patient showed that
ICP was within normal limits, which ruled out
papilledema. Therefore, we considered bilateral
hemorrhagic optic disc swelling due to lead toxi-
city. Neurological symptoms of lead toxicity, nor-
mal ICP (which ruled out idiopathic intracranial
hypertension), visual acuity impairment, positive
response to chelation therapy, and other clinical
and paraclinical evaluations confirmed that the
underlying cause was lead toxicity.
In cases of optic disc edema, physicians should
take a comprehensive history to detect the etiol-
ogy. In cases of chronic oral opium use, lead toxicity
should be considered, as lead is occasionally
added to the product.
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